Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Lippi G, Cadamuro J, von Meyer A, Simundic AM, on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE). Practical recommendations for managing hemolyzed samples in clinical chemistry testing. Clin Chem Lab Med 2018;56:718–27.10.1515/cclm-2017-1104Search in Google Scholar PubMed
2. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008;46:764–72.10.1515/CCLM.2008.170Search in Google Scholar PubMed
3. Barcellini W, Fattizzo B. Clinical applications of hemolytic markers in the differential diagnosis and management of hemolytic anemia. Dis Markers 2015;2015:635670.10.1155/2015/635670Search in Google Scholar PubMed PubMed Central
4. Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000;46:306–7.10.1093/clinchem/46.2.306Search in Google Scholar
5. Dolci A, Panteghini M. Harmonization of automated hemolysis index assessment and use: is it possible? Clin Chim Acta 2014;432:38–43.10.1016/j.cca.2013.10.012Search in Google Scholar PubMed
6. Dolci A, Giavarina D, Pasqualetti S, Szőke D, Panteghini M. Total laboratory automation: do stat tests still matter? Clin Biochem 2017;50:605–11.10.1016/j.clinbiochem.2017.04.002Search in Google Scholar PubMed
7. Aloisio E, Carnevale A, Pasqualetti S, Birindelli S, Dolci A, Panteghini M. Random uncertainty of photometric determination of hemolysis index on the Abbott Architect c16000 platform. Clin Biochem 2018;57:62–4.10.1016/j.clinbiochem.2018.01.009Search in Google Scholar PubMed
8. Pasqualetti S, Szőke D, Panteghini M. Heparinate but not serum tubes are susceptible to hemolysis by pneumatic tube transportation. Clin Chem Lab Med 2016;54:785–9.10.1515/cclm-2015-0751Search in Google Scholar PubMed
9. Clinical and Laboratory Standards Institute [CLSI]. Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis: approved guideline. CLSI document C56-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.Search in Google Scholar
10. Cadamuro J, Mrazek C, Haschke-Becher E, Sandberg S. To report or not to report: a proposal on how to deal with altered test results in hemolytic samples. Clin Chem Lab Med 2017;55:1109–11.10.1515/cclm-2016-1064Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
